The CLARITY-TIMI 28 ( Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction 28 ) trial randomized 3,491 patients with ST-segment elevation myocardial infarction ( STEMI ) undergoing fibrinolysis to clopidogrel versus placebo .
